US government stops distribution of Eli Lilly Covid-19 antibody treatment due to spread of coronavirus variants

Written by Annette

The US government in coordination with Eli Lilly said it will no longer distribute the Covid-19 monoclonal antibody therapy bamlanivimab for use on its own. The halt is due to the “sustained increase” in coronavirus variants in the United States.


About the author


Leave a Comment